475 related articles for article (PubMed ID: 20422001)
1. Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers.
Deng S; Yang X; Lassus H; Liang S; Kaur S; Ye Q; Li C; Wang LP; Roby KF; Orsulic S; Connolly DC; Zhang Y; Montone K; Bützow R; Coukos G; Zhang L
PLoS One; 2010 Apr; 5(4):e10277. PubMed ID: 20422001
[TBL] [Abstract][Full Text] [Related]
2. ALDH1-high ovarian cancer stem-like cells can be isolated from serous and clear cell adenocarcinoma cells, and ALDH1 high expression is associated with poor prognosis.
Kuroda T; Hirohashi Y; Torigoe T; Yasuda K; Takahashi A; Asanuma H; Morita R; Mariya T; Asano T; Mizuuchi M; Saito T; Sato N
PLoS One; 2013; 8(6):e65158. PubMed ID: 23762304
[TBL] [Abstract][Full Text] [Related]
3. Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species.
Mizuno T; Suzuki N; Makino H; Furui T; Morii E; Aoki H; Kunisada T; Yano M; Kuji S; Hirashima Y; Arakawa A; Nishio S; Ushijima K; Ito K; Itani Y; Morishige K
Gynecol Oncol; 2015 May; 137(2):299-305. PubMed ID: 25541259
[TBL] [Abstract][Full Text] [Related]
4. Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma.
Liebscher CA; Prinzler J; Sinn BV; Budczies J; Denkert C; Noske A; Sehouli J; Braicu EI; Dietel M; Darb-Esfahani S
Hum Pathol; 2013 Aug; 44(8):1465-71. PubMed ID: 23465277
[TBL] [Abstract][Full Text] [Related]
5. Aldehyde dehydrogenase 1, a functional marker for identifying cancer stem cells in human nasopharyngeal carcinoma.
Wu A; Luo W; Zhang Q; Yang Z; Zhang G; Li S; Yao K
Cancer Lett; 2013 Apr; 330(2):181-9. PubMed ID: 23220285
[TBL] [Abstract][Full Text] [Related]
6. Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
Ruscito I; Cacsire Castillo-Tong D; Vergote I; Ignat I; Stanske M; Vanderstichele A; Ganapathi RN; Glajzer J; Kulbe H; Trillsch F; Mustea A; Kreuzinger C; Benedetti Panici P; Gourley C; Gabra H; Kessler M; Sehouli J; Darb-Esfahani S; Braicu EI
Eur J Cancer; 2017 Jul; 79():214-225. PubMed ID: 28525846
[TBL] [Abstract][Full Text] [Related]
7. Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression.
Morimoto K; Kim SJ; Tanei T; Shimazu K; Tanji Y; Taguchi T; Tamaki Y; Terada N; Noguchi S
Cancer Sci; 2009 Jun; 100(6):1062-8. PubMed ID: 19385968
[TBL] [Abstract][Full Text] [Related]
8. ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcome.
Wang YC; Yo YT; Lee HY; Liao YP; Chao TK; Su PH; Lai HC
Am J Pathol; 2012 Mar; 180(3):1159-1169. PubMed ID: 22222226
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cell characteristics, ALDH1 expression in the invasive front of nasopharyngeal carcinoma.
Luo WR; Yao KT
Virchows Arch; 2014 Jan; 464(1):35-43. PubMed ID: 24248285
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive in situ analysis of ALDH1 and SOX2 reveals increased expression of stem cell markers in high-grade serous carcinomas compared to low-grade serous carcinomas and atypical proliferative serous tumors.
Fischer AK; Pham DL; Bösmüller H; Lengerke C; Wagner P; Bachmann C; Beschorner C; Perner S; Kommoss S; Fend F; Staebler A
Virchows Arch; 2019 Oct; 475(4):479-488. PubMed ID: 31451895
[TBL] [Abstract][Full Text] [Related]
11. Aldehyde dehydrogenase 1 expression in inflammatory breast cancer as measured by immunohistochemical staining.
Gong Y; Wang J; Huo L; Wei W; Ueno NT; Woodward WA
Clin Breast Cancer; 2014 Jun; 14(3):e81-8. PubMed ID: 24461456
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of association of cancer stem cell marker aldehyde dehydrogenase 1 with clinicopathological profile in lung carcinoma patients.
Tiwari N; Srivastava AN; Tandon N; Lal N; Yadav S; Kant S; Jain M
Indian J Pathol Microbiol; 2018; 61(4):489-494. PubMed ID: 30303135
[TBL] [Abstract][Full Text] [Related]
13. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.
Jiang F; Qiu Q; Khanna A; Todd NW; Deepak J; Xing L; Wang H; Liu Z; Su Y; Stass SA; Katz RL
Mol Cancer Res; 2009 Mar; 7(3):330-8. PubMed ID: 19276181
[TBL] [Abstract][Full Text] [Related]
14. Expression of aldehyde dehydrogenase 1 as a marker of mammary stem cells in benign and malignant breast lesions of Ghanaian women.
Schwartz T; Stark A; Pang J; Awuah B; Kleer CG; Quayson S; Kingman S; Aitpillah F; Abantanga F; Jiagge E; Oppong JK; Osei-Bonsu E; Martin I; Yan X; Toy K; Adjei E; Wicha M; Newman LA
Cancer; 2013 Feb; 119(3):488-94. PubMed ID: 22930220
[TBL] [Abstract][Full Text] [Related]
15. The expression of ALDH1 in cervical carcinoma.
Yao T; Chen Q; Zhang B; Zhou H; Lin Z
Med Sci Monit; 2011 Aug; 17(8):HY21-26. PubMed ID: 21804471
[TBL] [Abstract][Full Text] [Related]
16. Fibroblasts induce expression of FGF4 in ovarian cancer stem-like cells/cancer-initiating cells and upregulate their tumor initiation capacity.
Yasuda K; Torigoe T; Mariya T; Asano T; Kuroda T; Matsuzaki J; Ikeda K; Yamauchi M; Emori M; Asanuma H; Hasegawa T; Saito T; Hirohashi Y; Sato N
Lab Invest; 2014 Dec; 94(12):1355-69. PubMed ID: 25329002
[TBL] [Abstract][Full Text] [Related]
17. Aldehyde dehydrogenase 1, a potential marker for cancer stem cells in human sarcoma.
Lohberger B; Rinner B; Stuendl N; Absenger M; Liegl-Atzwanger B; Walzer SM; Windhager R; Leithner A
PLoS One; 2012; 7(8):e43664. PubMed ID: 22928012
[TBL] [Abstract][Full Text] [Related]
18. Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients.
Aktas B; Tewes M; Fehm T; Hauch S; Kimmig R; Kasimir-Bauer S
Breast Cancer Res; 2009; 11(4):R46. PubMed ID: 19589136
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of the expression of ALDH1 and SOX2 in urothelial cancer of the upper urinary tract.
Kitamura H; Torigoe T; Hirohashi Y; Asanuma H; Inoue R; Nishida S; Tanaka T; Fukuta F; Masumori N; Sato N; Tsukamoto T
Mod Pathol; 2013 Jan; 26(1):117-24. PubMed ID: 22899292
[TBL] [Abstract][Full Text] [Related]
20. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis.
Huang EH; Hynes MJ; Zhang T; Ginestier C; Dontu G; Appelman H; Fields JZ; Wicha MS; Boman BM
Cancer Res; 2009 Apr; 69(8):3382-9. PubMed ID: 19336570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]